ONon behalf of the Italian Working Group on RSV Prophylaxis of Italian Society of Neonatology
on behalf of the Italian Working Group on RSV Prophylaxis of Italian Society of Neonatology
+16
Respiratory syncytial virus (RSV) remains a leading cause of lower respiratory tract infection (LRTI) and hospitalization in early infancy. Following the introduction of universal nirsevimab prophylaxis in Italy during the 2024–2025 RSV season, we evaluated its real-world effectiveness against RSV-associated hospitalization and severe clinical outcomes within a test-negative design framework. We conducted a multicenter retrospective test-negative study across 88 Italian neonatal centers, including infants hospitalized for LRTI from 1 September 2024 to 30 April 2025. Clinical data were collected from hospital records using a standardized electronic questionnaire. RSV-positive hospitalized infants were considered cases, and RSV-negative hospitalized infants served as controls. Secondary outcomes included respiratory support and Neonatal Intensive Care Unit (NICU) admission. Effectiveness was estimated using multivariable logistic regression and targeted maximum likelihood estimation. Overall, 737 infants were included, of whom 306 (41.52%) had previously received nirsevimab. RSV infection was identified in 398 infants (54.00%), including 104/306 (33.99%) nirsevimab-immunized and 294/431 (68.21%) non-immunized infants (p < 0.001). Immunized infants also required respiratory support less frequently (55.23% vs. 70.07%; p < 0.001), with lower use of high-flow oxygen therapy (40.85% vs. 48.96%; p = 0.036) and Continuous Positive Airway Pressure (CPAP) (18.95% vs. 33.87%; p < 0.001). Within the test-negative design framework, adjusted effectiveness against RSV-associated hospitalization was estimated at 78.3%. Among hospitalized infants, previous nirsevimab immunization was additionally associated with adjusted relative reductions in the odds of respiratory support and NICU admission of 80.2% and 64.3%, respectively. In conclusion, among infants hospitalized for LRTI in routine Italian clinical practice, previous nirsevimab immunization was associated with lower odds of RSV positivity and a reduced need for respiratory support. Although these findings provide further evidence of the real-world effectiveness of nirsevimab against severe RSV disease, further studies are needed to provide direct estimates of hospitalization incidence in immunized and non-immunized source populations.
Background/Objectives: Breastfeeding is universally recognized as essential for neonatal health, offering benefits that extend into later life stages. The World Health Organization (WHO) advocates for increasing access to effective, low-cost interventions that promote successful breastfeeding, such as skin-to-skin contact (SSC), kangaroo mother care (KMC), and rooming-in. This study aimed to assess the local context regarding the use and dissemination of practices such as prenatal classes, immediate and post-delivery SSC, rooming-in, and the management of discharge and post-discharge care. Methods: This study is a cross-sectional survey across all 29 birth centers in two regions of Southern Italy. An online questionnaire was distributed to all neonatal units, and local data were compared with national, European, and global datasets. Results: Childbirth preparation classes were offered by 38% of centers. Fifteen centers routinely implemented SSC in the first two hours postpartum, while 12 centers used SSC for a shorter duration. Rooming-in was practiced in all centers, with 8 of 29 centers (27.6%) offering it on a full 24 h basis. A brief postpartum follow-up dedicated to breastfeeding support was provided in 12 of 29 centers (41.4%), and 6 centers offered a dedicated telephone breastfeeding consultation service. Conclusions: This survey confirmed the value of monitoring adherence to breastfeeding promotion practices at the regional level, within a broader national and global framework. Differences between units indicate the need for targeted interventions to implement all known, evidence-based methods for promoting breastfeeding initiation.